Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-13

Clinical Trial Update: Efficacy and Safety of Apremilast in Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating efficacy and safety of apremilast in psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apremilast (apremilast)

Snippet

Sponsor: Ghurki Trust and Teaching Hospital | Conditions: Psoriasis | Phase 4 | Status: COMPLETED